Version 3 Criteria coming soon!
The Criteria for Immunoglobulin Use in Australia (the Criteria) is changing to Version 3 from 22 October 2018.
The Criteria will be released electronically within BloodSTAR and will also be available at criteria.blood.gov.au. A printed version will no longer be available. From October 22 information for each medical condition can be printed from BloodSTAR or criteria.blood.gov.au if required, but any printed version must regularly be checked for currency.
Summary of medical condition changes by specialty for Health Professionals
Haematology conditions summary of changes (3.9 MB)- Immunology condition summary of changes (3.96 MB)
- Neurology conditions summary of changes (4.02 MB)
- Transplantation conditions summary of changes (2.89 MB)
Conditions as they appear in the Criteria
|
Haematology conditions |
Immunology condition |
Neurology conditions |
Transplantation conditions |
|
Acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT) |
Anti-neutrophil cytoplasmic antibody (ANCA) [Proteinase 3 (PR3) or myeloperoxidase (MPO)] - positive systemic necrotising vasculitis |
Acute disseminated encephalomyelitis (ADEM) |
Solid organ transplantation |
|
Autoimmune haemolytic anaemia (AIHA) |
Autoimmune congenital heart block |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens (AMAE) |
|
|
Autoimmune neutropenia |
Autoimmune retinopathy (AIR) |
Childhood epileptic encephalopathy |
|
|
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) |
Bullous pemphigoid (BP) |
Chronic inflammatory demyelinating polyneuropathy (CIDP), (including IgG and IgA paraproteinaemic demyelinating neuropathies) |
|
|
Haemolytic disease of the fetus (HDF) |
Catastrophic anti-phospholipid syndrome (CAPS) |
Guillain–Barré Syndrome including variants (GBS) |
|
|
Haemolytic transfusion reaction (hyperhaemolysis syndrome)
|
Cicatricial pemphigoid (CP) or Mucous Membrane Pemphigoid (MMP) |
IgM paraproteinaemic demyelinating neuropathy |
|
|
Immune thrombocytopenic purpura (ITP) — adult |
Epidermolysis bullosa acquisita |
Inflammatory Myopathies: Inclusion Body Myositis (IBM) |
|
|
Immune thrombocytopenic purpura (ITP) — in children 15 years and younger |
Graves ophthalmopathy |
Inflammatory myopathies: polymyositis (PM), dermatomyositis (DM) and necrotising autoimmune myopathy (NAM) |
|
|
Neonatal haemochromatosis (NH) |
Kawasaki disease (mucocutaneous lymph node syndrome) |
Lambert–Eaton myasthenic syndrome (LEMS) |
|
|
Post-transfusion purpura (PTP) |
Pemphigus foliaceus (PF) |
Multifocal motor neuropathy (MMN) |
|
|
Pure red cell aplasia (PRCA) |
Pemphigus vulgaris (PV) |
Multiple sclerosis - (MS) [relapsing remitting multiple sclerosis (RRMS)] |
|
|
Haemophagocytic lymphohistiocytosis (HLH) |
Primary immunodeficiency diseases (PID) with antibody deficiency |
Myasthenia gravis (MG) |
|
|
Acquired haemophilia and congenital haemophilia with inhibitors (Coagulation factor inhibitors) |
Pyoderma Gangrenosum (PG) |
Neuromyelitis optica spectrum disorders (NMOSD) |
|
|
|
Scleromyxedema |
Opsoclonus-myoclonus ataxia (OMA) |
|
|
|
Secondary hypogammaglobulinaemia unrelated to Haematological malignancy or haemopoeitic stem cell transplant (HSCT) |
Paediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) or paediatric acute neuropsychiatric disorders (PANS) |
|
|
|
Specific antibody deficiency |
Rasmussen encephalitis |
|
|
|
Systemic capillary leak syndrome |
Sjögren’s syndrome associated neuropathy |
|
|
|
Toxic epidermal necrolysis (TEN; Lyell syndrome) / Stevens–Johnson syndrome (SJS) |
Stiff person syndrome |
|
|
|
Toxic shock syndrome (TSS) |
Susac syndrome |
|
Other conditions
| No longer supported conditions |
|
Diabetic amyotrophy
|
|
HIV in children
|
|
Myocarditis in children
|
|
Paraneoplastic neurological syndromes - cerebellar degeneration
|
|
Paraneoplastic neurological syndromes - subacute sensory neuropathy
|
|
Pure white cell aplasia (PWCA)
|
| No longer stand-alone conditions | May now apply using |
| Acute leukaemia |
Acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation [HSCT] Factsheet (1.41 MB) |
| Evans syndrome or Autoimmune haemolytic anaemia with immune thrombocytopenia (AIHA with ITP) |
Autoimmune haemolytic anaemia [AIHA]
Immune thrombocytopenic purpura [ITP] – adult
Immune thrombocytopenic purpura [ITP] – in children 15 years and younger Factsheet (1.41 MB) |
| Hashimoto encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis) |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet (1.41 MB) |
| Kidney transplantation |
Solid organ transplantation Factsheet (1.42 MB) |
| Limbic encephalitis – nonparaneoplastic |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet (1.41 MB) |
| Paraneoplastic neurological syndromes - limbic encephalitis |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet (1.41 MB) |
| Potassium channel antibody-associated encephalopathy |
Autoimmune encephalitis mediated by antibodies targeting cell-surface antigens [AMAE] Factsheet (1.41 MB) |
| Solid organ transplantation (other than kidney) |
Solid organ transplantation Factsheet (1.42 MB) |
Print